CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy

Glioblastoma is the most common and aggressive type of brain tumor with high recurrence and fatality rates. Although various therapeutic strategies have been explored, there is currently no effective treatment for glioblastoma. Recently, the number of immunotherapeutic strategies has been tested for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hara, Ayaka, Koyama-Nasu, Ryo, Takami, Mariko, Toyoda, Takahide, Aoki, Takahiro, Ihara, Fumie, Kobayashi, Masayoshi, Hirono, Seiichiro, Matsutani, Tomoo, Nakayama, Toshinori, Iwadate, Yasuo, Motohashi, Shinichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053161/
https://www.ncbi.nlm.nih.gov/pubmed/33128583
http://dx.doi.org/10.1007/s00262-020-02742-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053161/
https://www.ncbi.nlm.nih.gov/pubmed/33128583
http://dx.doi.org/10.1007/s00262-020-02742-1

Ejemplares similares